SG Americas Securities LLC lifted its stake in shares of Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) by 883.4% during the third quarter, Holdings Channel reports. The fund owned 169,215 shares of the company’s stock after buying an additional 152,008 shares during the quarter. SG Americas Securities LLC’s holdings in Senseonics were worth $574,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Aristides Capital LLC acquired a new position in shares of Senseonics during the 2nd quarter valued at $38,000. Kestra Advisory Services LLC acquired a new position in shares of Senseonics during the 3rd quarter valued at $38,000. Comerica Bank acquired a new position in shares of Senseonics during the 2nd quarter valued at $36,000. Advisory Services Network LLC acquired a new position in shares of Senseonics during the 2nd quarter valued at $44,000. Finally, Profund Advisors LLC acquired a new position in shares of Senseonics during the 2nd quarter valued at $47,000. Institutional investors own 26.64% of the company’s stock.
Senseonics stock opened at $2.84 on Friday. Senseonics Holdings, Inc. has a 52 week low of $1.48 and a 52 week high of $5.56. The company has a market cap of $1.27 billion, a price-to-earnings ratio of -1.99 and a beta of 0.44.
In related news, COO Mukul Jain sold 100,000 shares of Senseonics stock in a transaction that occurred on Tuesday, November 16th. The shares were sold at an average price of $3.70, for a total value of $370,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Anthony R. Raab sold 136,538 shares of Senseonics stock in a transaction that occurred on Monday, December 6th. The stock was sold at an average price of $2.53, for a total transaction of $345,441.14. The disclosure for this sale can be found here. Insiders sold a total of 257,536 shares of company stock worth $793,134 in the last ninety days. 5.60% of the stock is currently owned by insiders.
Separately, Zacks Investment Research lowered shares of Senseonics from a “buy” rating to a “hold” rating in a research note on Wednesday, November 17th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $3.95.
Senseonics Holdings, Inc engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Read More: What is the market perform rating?
Want to see what other hedge funds are holding SENS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Senseonics Holdings, Inc. (NYSEAMERICAN:SENS).
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.